Mid-Cycle Communication Document, July 17, 2013 - ALPROLIX

From: Thompson, Edward
Sent: Wednesday, July 17, 2013 8:31 AM
To: 'Nadine D. Cohen PhD (nadine.cohen@biogenidec.com)'
Cc: Debra Segal; Kirschbaum, Nancy (Nancy.Kirschbaum@fda.hhs.gov)
Subject: Mid-Cycle Communication Document for BL 125444/0

Contacts: Nadine D. Cohen PhD

Dear Dr. Cohen,

Please find attached the Mid-Cycle Communication for BL 125444/0 from Wednesday, June 19, 2013.

If you require clarification in regards to this document, please contact me.

Sincerely,


 Edward Thompson
 Regulatory Project Manager
 HFM-380 FDA/CBER
 Office of Blood Research and Review
 Division of Blood Applications
 301-827-9167, Fax 301-827-2857
 email: edward.thompson@fda.hhs.gov
 1401 Rockville Pike, Room 554N
 Rockville, MD 20852-1448
